Owen J.D. Alexander

  • 330 North Wabash Avenue, Suite 2800
  • Chicago, IL 60611
  • USA
Profile Experience

Owen Alexander is a corporate associate in the Chicago office of Latham & Watkins. Mr. Alexander advises public and private companies and private equity firms on a range of transactions, including:

  • Public and private mergers and acquisitions 
  • Friendly and unsolicited tender offers
  • Going-private transactions
  • Takeover defense counseling
  • Joint ventures
  • Company representation matters

Mr. Alexander has also served as a mediator in New York City Civil Court and Jersey City Small Claims Court. He is a former member of Latham's Associates Committee.

Mr. Alexander's experience includes representing:

  • GNC Holdings, a retailer of health, wellness, and performance products, in its US$300 million sale of preferred stock to Harbin Pharmaceutical Group
  • GTCR in its US$1.65 billion strategic investment in Vivid Seats, an independent marketplace for tickets to live sports, concert, and theater events
  • Entercom Communications in its US$3 billion merger with CBS Radio, to create a nationwide preeminent radio platform
  • Onex Corporation in its US$1.37 billion acquisition of the Save-A-Lot business of SUPERVALU, a hard-discount grocery retailer
  • Press Ganey, a provider of patient experience measurement, performance analytics, and strategic advisory solutions to hospitals and healthcare providers, in its US$2.35 billion sale to EQT Partners
  • Columbus McKinnon Corporation in its US$191 million acquisition of Magnetek, a manufacturer of digital power and motion control systems
  • Orbitz Worldwide, Inc. in its US$1.6 billion sale to Expedia
  • The Carlyle Group in its acquisition of Novetta Solutions LLC
  • Tribune Publishing Company in its US$44.4 million private placement with Merrick Media, LLC
  • Koch Optics in its US$445 million acquisition of Oplink Communications, a provider of optical communications components
  • INVISTA in its joint venture agreement for, and related settlement of IP disputes over, the Butachimie joint venture with Solvay which operates the world’s largest adiponitrile facility
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.